心房颤动市场：按程序（药理学、非药理学）、技术、最终用户（医院、专家、诊所、其他）、地区 - 规模、份额、展望、机会分析，2022-2030 年

心房颤动是一种心律失常，其特征是心臟电气系统紊乱引起的异常心跳。房颤被认为是最常见的心律失常之一。缓慢、快速或不规则的心跳称为心律失常。未经治疗的房颤可导致中风和其他严重并发症。如果您患有糖尿病、高血压或其他心脏病，房颤可能很危险。

心房颤动可以作为单次发作或慢性疾病、心律不齐、心律失常、虚弱、头晕、疲劳和其他症状发生。心房颤动通常是由混乱的信号引起的，这些信号会导致心臟的两个顶部腔室，即心房，快速而不合时宜地收缩。由于心房收缩如此之快，心壁颤动。心房颤动可由心臟电系统受损引起。在心房颤动中，心臟上腔的信号被破坏。结果，上心室颤动。然后，房室结试图到达下心室，衝动衝入（心室）。这会导致快速、不规则的心跳。

市场动态

酒精的大量消费预计也有助于市场增长。例如，根据 2021 年 8 月发布的数据，美国分析和咨询公司盖洛普表示，到 2021 年，约 60% 的美国成年人将饮用酒精饮料。

这项研究的主要特点

• 本报告对全球心房颤动市场进行了深入分析，显示了以 2021 年为基准年的预测期（2022-2030 年）内市场规模和復合年增长率 (CAGR%) 的增长。
• 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
• 它还提供重要见解，包括市场驱动因素、制约因素、机会、新产品发布和批准、市场趋势、区域前景以及主要参与者采用的竞争战略。
• 根据公司亮点、产品组合、主要亮点、绩效和战略等参数介绍全球心房颤动市场主要参与者的概况。
• 本研究涵盖的主要公司包括 AtriCure, Inc.、Biosense Webster, Inc.、Boehringer Ingelheim GmbH、波士顿科学公司、Bristol-Myers Squibb Corporation、CardioFocus, Inc.、Endoscopic Technologies, Inc.、Sanofi Aventis 、强生有限公司和雅培实验室。
• 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
• 《全球心房颤动市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球心房颤动市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按程序
  • 市场概况：按技术分类
  • 市场概况：按最终用户分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
• 影响分析
• 市场趋势
• 近期趋势
• 收购和合作场景
• 技术概览
• 监管情景
• 管道分析
• 害虫分析

第 4 章全球心房颤动市场 - 冠状病毒 (COVID-19) 大流行的影响

• 总体影响
• 对供需的影响
• COVID-19 对市场的影响

第 5 章全球心房颤动市场：按程序，2017-2030

• 药理学
• 通过药理学方法
• 非药物性

第 6 章全球心房颤动市场：按技术分类，2017-2030

• 无线电波
• 激光
• 冷冻疗法
• 其他

第 7 章全球心房颤动市场：按最终用户分类，2017-2030

• 医院
• 专科诊所
• 其他

第 8 章全球房颤市场：地区，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第9章竞争格局

• AtriCure, Inc, Inc
• Biosense Webster
• Boehringer Ingelheim GmbH
• Boston Scientific Corporation
• Bristol-Myers Squibb Corporation
• CardioFocus, Inc.
• Endoscopic Technologies, Inc
• Sanofi Aventis
• Johnson and Johnson Ltd.
• Abbott Laboratories
• Research Methodology
• About Us

Atrial fibrillation is a type of cardiac arrhythmia distinguished by an abnormal cardiac rhythm caused by a disturbance in heart's electrical system. It is considered to be one of the most prevalent types of cardiac arrhythmia. When the heart beats too slowly, too quickly, or irregularly, it is called an arrhythmia. Atrial fibrillation if untreated, can lead to a stroke and other serious medical complications. Atrial fibrillation can be dangerous if a person have diabetes, high blood pressure or other diseases of the heart.

Atrial fibrillation may occur in isolated incidents or it may be a chronic illness, fluttering heartbeat, irregular pulse, weakness, dizziness, and fatigue. Atrial fibrillation is mostly brought on by chaotic signals that cause the atria, the two top chambers of your heart, to contract quickly and out of time. Because of how swiftly they contract, the heart's walls fibrillate. Atrial fibrillation may result from electrical system damage to your heart. The signals in the upper chambers of the heart are disorganized in atrial fibrillation. The outcome is a shaking of the higher chambers (quiver). The lower cardiac chambers are then attempted to be reached by the AV node, which is then inundated with impulses (ventricles). A quick and erratic heart rhythm results from this.

Market Dynamics

High consumption of alcohol is also expected to aid in growth of the market. For instance, according to data published on August 2021, on Gallup, Inc, which is an U.S. analytics and advisory company, stated that about 60% of U.S. adults drink alcoholic beverages in 2021.

Key features of the study:

• This report provides an in-depth analysis of the global atrial fibrillation market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global atrial fibrillation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd., and Abbott Laboratories.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global atrial fibrillation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global atrial fibrillation market

Detailed Segmentation:

• Global Atrial Fibrillation Market, By Procedure:
  • Pharmacological
    • Anti-arrhythmic
    • Anti-coagulant
  • Non-Pharmacological
    • Catheter Ablation Procedures
    • Maze surgery
    • Electric Cardioversion
• Global Atrial Fibrillation Market, By Technology:
  • Radiofrequency
  • Laser
  • Cryotherapy
  • Others
• Global Atrial Fibrillation Market, By End User:
  • Hospitals
  • Speciality Clinics
  • Others
• Global Atrial Fibrillation Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • AtriCure, Inc.
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Biosense Webster, Inc
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Corporation
  • CardioFocus, Inc.
  • Endoscopic Technologies, Inc.
  • Sanofi Aventis
  • Johnson and Johnson Ltd
  • Abbott Laboratories

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Procedure
  • Market Snapshot, By Technology
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pipeline Analysis
• PEST Analysis

4. Global Atrial Fibrillation Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Atrial Fibrillation Market, By Procedure, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pharmacological
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• By Pharmacological
  • Anti-arrhythmic
  • Anti-coagulant
• Non-Pharmacological
  • Catheter Ablation Procedures,
  • Maze surgery,
  • Electric Cardioversion

6. Global Atrial Fibrillation Market, By Technology, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Radiofrequency
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Laser
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cryotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Atrial Fibrillation Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Specialty clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Atrial Fibrillation Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• AtriCure, Inc, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biosense Webster
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Boston Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bristol-Myers Squibb Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• CardioFocus, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Endoscopic Technologies, Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sanofi Aventis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson and Johnson Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Research Methodology
• About Us